Laura Stiles

Lofexidine may expand the treatment options available for managing withdrawal when buprenorphine and methadone are unavailable or undesirable.

Borderline personality disorder, a disorder that is often misunderstood by the general public, also raises questions for psychiatrists.

At 6 weeks of treatment, severely ill patients treated with adjunctive brexpiprazole had a greater reduction in PANSS total scores and CGI-S scores compared with those receiving placebo.

This research provides further support to compelling data linking inflammation and depression.

The researchers believe this study is the first to detect a statistically significant, unexpected inverse association between efavirenz use and depression.

The researchers found significant advantages from dialectical behavior therapy in all primary outcomes.

The Janssen Pharmaceutical Companies of Johnson & Johnson have announced the results of 2 long-term phase 3 clinical trials examining esketamine nasal spray in patients with treatment-resistant depression.

Widespread use of antidepressants may be contributing to long-term increased risk for weight gain.

Dr Stewart has held executive leadership positions in public behavioral health systems in Michigan, New York, and Pennsylvania. Her career has spanned 3 decades in public sector administration.

This study had a sample size large enough to assess the effect of circadian disruption on mental health disorders, and was the first to objectively measure patterns of rest and activity (using accelerometers).